"About all I can say for the United States Senate is that it opens with a prayer and closes with an investigation." - Will Rogers
Today, we look at an interesting small-cap concern making the transition into commercialization after a recent FDA approval. Like about everything in the market over the past month, the shares have been hit hard despite solid progress at the company.
Company Overview
Epizyme (EPZM) is a Massachusetts-based biopharmaceutical company that IPO'd in 2013. The company is harnessing the power of epigenetics in the form of therapeutics to